Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug metabolizing enzymes-associated chemo resistance and strategies to overcome it
Himanshu Verma, Malkeet Singh Bahia, Shalki Choudhary, et al.
Drug Metabolism Reviews (2019) Vol. 51, Iss. 2, pp. 196-223
Closed Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Cytochrome P450 Enzymes and Drug Metabolism in Humans
Mingzhe Zhao, Jingsong Ma, Mo Li, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12808-12808
Open Access | Times Cited: 506
Understanding and targeting resistance mechanisms in cancer
Zi‐Ning Lei, Tian Qin, Qiu‐Xu Teng, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 89
Drug-Metabolizing Cytochrome P450 Enzymes Have Multifarious Influences on Treatment Outcomes
Yurong Song, Chenxi Li, Guangzhi Liu, et al.
Clinical Pharmacokinetics (2021) Vol. 60, Iss. 5, pp. 585-601
Closed Access | Times Cited: 66
Identification of approved drugs with ALDH1A1 inhibitory potential aimed at enhancing chemotherapy sensitivity in cancer cells: an in-silico drug repurposing approach
Sanjay Kumar Paul, Abdelmadjid Guendouzi, Agniswar Banerjee, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-15
Closed Access | Times Cited: 7
Molecular mechanisms associated with chemoresistance in esophageal cancer
Matheus Lohan-Codeço, Maria Luísa Barambo-Wagner, Luiz Eurico Nasciutti, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 2
Open Access | Times Cited: 31
The role of UDP-glycosyltransferases in xenobioticresistance
Diana Dimunová, Petra Matoušková, Radka Podlipná, et al.
Drug Metabolism Reviews (2022) Vol. 54, Iss. 3, pp. 282-298
Closed Access | Times Cited: 31
Autophagy orchestrates resistance in hepatocellular carcinoma cells
Homeyra Seydi, Kosar Nouri, Niloufar Rezaei, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114487-114487
Open Access | Times Cited: 20
Designing cytochrome P450 enzymes for use in cancer gene therapy
Saskya E. Carrera-Pacheco, Alexander Mueller, Juan A. Puente-Pineda, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 5
Insight into the structure, oligomerization, and the role in drug resistance of human UDP-glucuronosyltransferases
Xue Jia, Qiuyi Li, Yao Wang, et al.
Archives of Toxicology (2025)
Closed Access
The Adaptation of MCF-7 Breast Cancer Spheroids to the Chemotherapeutic Doxorubicin: The Dynamic Role of Phase I Drug Metabolizing Enzymes
Daniel Crispim, Carolina Ramos, Francisco Esteves, et al.
Metabolites (2025) Vol. 15, Iss. 2, pp. 136-136
Open Access
Lymphovascular invasion is associated with doxorubicin resistance in breast cancer
Allen Joy M. Corachea, Regina Joyce E Ferrer, Lance Patrick B Ty, et al.
Laboratory Investigation (2025), pp. 104115-104115
Closed Access
DPP9 regulates NQO1 and ROS to promote resistance to chemotherapy in liver cancer cells
Yunjiang Zhou, Yaxin Chen, Chenyuan Xuan, et al.
Redox Biology (2024) Vol. 75, pp. 103292-103292
Open Access | Times Cited: 4
piR-39980 mediates doxorubicin resistance in fibrosarcoma by regulating drug accumulation and DNA repair
Basudeb Das, Neha Jain, Bibekanand Mallick
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 29
Genomic Landscape and Potential Regulation of RNA Editing in Drug Resistance
Xu Zhou, Ramkrishna Mitra, Fei Hou, et al.
Advanced Science (2023) Vol. 10, Iss. 14
Open Access | Times Cited: 11
PCK1-mediated glycogenolysis facilitates ROS clearance and chemotherapy resistance in cervical cancer stem cells
Xinxin Chen, Nan Yang, Ying Wang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Sub-lethal doses of albendazole induce drug metabolizing enzymes and increase albendazole deactivation in Haemonchus contortus adults
Pavlína Kellerová, Lucie Raisová Stuchlíková, Petra Matoušková, et al.
Veterinary Research (2020) Vol. 51, Iss. 1
Open Access | Times Cited: 27
βIII-tubulin overexpression in cancer: Causes, consequences, and potential therapies
Arun Kanakkanthara, John H. Miller
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 2, pp. 188607-188607
Open Access | Times Cited: 26
The relationship between UGT1A1 gene & various diseases and prevention strategies
Dan Liu, Qi Yu, Qing Ning, et al.
Drug Metabolism Reviews (2021) Vol. 54, Iss. 1, pp. 1-21
Closed Access | Times Cited: 26
Role of Genetic Polymorphisms in Drug-Metabolizing Enzyme-Mediated Toxicity and Pharmacokinetic Resistance to Anti-Cancer Agents: A Review on the Pharmacogenomics Aspect
Gera Narendra, Shalki Choudhary, Baddipadige Raju, et al.
Clinical Pharmacokinetics (2022) Vol. 61, Iss. 11, pp. 1495-1517
Closed Access | Times Cited: 15
Development of Novel N-Aryl-2,4-bithiazole-2-amine-Based CYP1B1 Degraders for Reversing Drug Resistance
Xiaoxuan Yao, Jianping Mao, Haoyu Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116488-116488
Closed Access | Times Cited: 2
Metallothionein-3 promotes cisplatin chemoresistance remodelling in neuroblastoma
Miguel Angel Merlos Rodrigo, Hana Michalkova, Vladislav Strmiska, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 19
Cancer Stem Cells: Biology and Therapeutic Implications
Héctor Mayani, Antonieta Chávez‐González, Karla Vázquez-Santillán, et al.
Archives of Medical Research (2022) Vol. 53, Iss. 8, pp. 770-784
Open Access | Times Cited: 12
3D‐QSAR and scaffold hopping based designing of benzo[d]ox‐azol‐2(3H)‐one and 2‐oxazolo[4,5‐b]pyridin‐2(3H)‐one derivatives as selective aldehyde dehydrogenase 1A1 inhibitors: Synthesis and biological evaluation
Himanshu Verma, Gera Narendra, Baddipadige Raju, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 9
Closed Access | Times Cited: 11
Dihydropyrimidine Dehydrogenase-Mediated Resistance to 5-Fluorouracil: Mechanistic Investigation and Solution
Himanshu Verma, Gera Narendra, Baddipadige Raju, et al.
ACS Pharmacology & Translational Science (2022) Vol. 5, Iss. 11, pp. 1017-1033
Open Access | Times Cited: 11
Discovery of 4’-trifluoromethylchalcones as novel, potent and selective hCYP1B1 inhibitors without concomitant AhR activation
Yue Wu, Jin-Hui Shi, Guanghao Zhu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115552-115552
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top